News

Stocks that are crashing in value can sometimes make for good contrarian investments -- provided that there's a reason to expect a turnaround. But in some situations, investors are better off just

Healthcare ranks as one of the top expenses for many retirees. And it's about to become even more expensive.

Last week, the Centers for Medicare and Medicaid Services (CMS) announced the amounts of

Pharmaceutical giant Pfizer (NYSE: PFE) wasn't looking very tall or strong on the stock exchange Tuesday. The company's share price dipped by nearly 2% over the course of the trading session

Industries with endless demand are great places to find dividend stocks. Healthcare might be the best example of this. No matter how much technology changes, the need to prevent and treat disease

Although sometimes risky and volatile, the biotech industry is an excellent place to find stocks that can generate steady returns for years. That's because these companies tend to offer products

Telecom giant AT&T (NYSE: T) has been through a lot in recent years.

The company's foray into entertainment media operations ended with the spinoff of WarnerMedia to create the new Warner Bros

This vaccination season could be a key moment for vaccine makers and investors. That's because it's offering us a first glimpse into the future coronavirus vaccine revenue opportunity. Companies

Want to invest in stocks that you can buy and forget about? If so, you'll want to consider companies with plenty of long-term growth opportunities and solid financials. Among the best growth

The three most prominent themes in stock investing this year have been artificial intelligence (AI), weight-loss care, and profitability. Companies with strong profitability and/or ties to AI and

If you had bought Novavax's (NASDAQ: NVAX) shares at the beginning of 2020, you'd be sitting on solid gains. The stock skyrocketed soon after the pandemic started as Novavax raced to develop a

Pfizer (NYSE: PFE) and Gilead Sciences (NASDAQ: GILD) are two of the world's largest and most prominent drugmakers, not that this has somehow prevented investors from selling off their shares this

The stock market tends to go overboard from time to time. There are legitimate reasons investors should be wary of AT&T (NYSE: T) and Hanesbrands (NYSE: HBI), for example. The telecom giant is

Vertex Pharmaceuticals (NASDAQ: VRTX) is a growing business that generates billions in annual profit and has some incredible opportunities ahead. It's easy to see why investors are bullish on the

What's better than a stock that pays dividends? A stock with growing dividends and a business that's built for long-term success. 

Three Motley Fool contributors identified stocks they think fit the

Shares of Revolution Medicines (NASDAQ: RVMD) were up more than 20% as of 2 p.m. ET after the company announced positive phase 1/1b trial data for two cancer therapies. The clinical-stage biotech's

Shares of Vertex Energy (NASDAQ: VTNR) zoomed on Friday and were trading 10% higher as of 11 a.m. ET after the company projected better-than-expected throughput volumes for its third quarter. The

Shares of T2 Biosystems (NASDAQ: TT00) were down more than 46% as of 10:45 a.m. on Friday after the healthcare company announced preliminary third-quarter earnings and a reverse stock split on

On Oct. 1, Viatris (NASDAQ: VTRS) made an announcement that's sure to shake up its fortunes. It's divesting nearly all of its over-the-counter (OTC) medicines, its entire women's healthcare segment

Large companies often turn to acquisitions to jump-start revenue and earnings growth or to speed up research and development, among other reasons. However, these moves aren't always successful, so

Bristol Myers Squibb (NYSE: BMY) has historically been a growth machine, always on the hunt for acquisitions and ways to get bigger and better. But acquisitions have also been a bit of a necessity

The last few years have been tough sledding for shareholders of AT&T (NYSE: T). The telecommunications giant made some blunders last decade, none more impactful than its purchase of Time Warner. The

The U.S. Federal Trade Commission (FTC) allowed Amgen's (NASDAQ: AMGN) purchase of Horizon Therapeutics to go through last month and the company announced the closing of the deal in a press release

AT&T (NYSE: T) wasn't headed into the weekend on a high note. On Thursday, the incumbent telecom stock lost 2% of its value, not least because a pundit reduced his price target. That decline was

Over the course of 2007 to 2021, growth stocks dramatically outperformed value stocks. Historically low interest rates, coupled with the emergence of the knowledge economy, sparked one of the

Novavax (NASDAQ: NVAX) fell behind in the original coronavirus vaccine race as rivals Pfizer and Moderna brought their products to market. The biotech launched its vaccine a year-and-a-half later in